TITLE

Use of progression-free survival as a surrogate marker in oncology trials: some regulatory issues

AUTHOR(S)
Chakravarty, Aloka; Sridhara, Rajeshwari
PUB. DATE
October 2008
SOURCE
Statistical Methods in Medical Research;Oct2008, Vol. 17 Issue 5, p515
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
There has been interest in using progression-free survival as a surrogate endpoint for overall survival in oncology clinical trials. In order to objectively define this endpoint, clear understanding of what progression means, how it is measured and what its implications are need to be discussed. This article discusses some regulatory aspects of using progression-free survival as an endpoint.
ACCESSION #
35355529

 

Related Articles

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics